Paclitaxel (P) and cisplatin (C) concurrent with radiotherapy (RT) for larynx preservation (LP) in advanced resectable laryngeal (L) and hypopharyngeal (HP) squamous cell carcinoma (SCC): Final results of a prospective multicenter phase II trial

被引：0

作者：

Bueno, Thiago de Oliveira ^{[1
]}

Carvalho, Andre Lopes ^{[4
]}

Assis Pellizzon, Antonio Cassio ^{[3
]}

Pereira, Augusto ^{[1
]}

dos Santos, Carlos Roberto ^{[4
]}

Kowalski, Luiz Paulo ^{[2
]}

Viana, Luciano ^{[5
]}

Duarte, Marcos ^{[6
]}

Pierre, Renato ^{[7
]}

de Santana, Rosane Oliveira ^{[8
]}

Lincoln, Ricardo ^{[9
]}

Nicolau, Ulisses Ribaldo ^{[1
]}

Feher, Olavo ^{[10
]}

机构：

[1] Hosp AC Camargo Fund Antonio Prudente, Dept Med Oncol, Sao Paulo, Brazil

[2] Hosp AC Camargo Fund Antonio Prudente, Dept Head & Neck Surg, Sao Paulo, Brazil

[3] Hosp AC Camargo Fund Antonio Prudente, Dept Radiotherapy, Sao Paulo, Brazil

[4] Hosp Canc Barretos, Fundacao Pio 12, Dept Head & Neck Surg, Barretos, Brazil

[5] Hosp Canc Barretos, Fundacao Pio 12, Dept Med Oncol, Barretos, Brazil

[6] Hosp Canc Barretos, Fundacao Pio 12, Dept Radiotherapy, Barretos, Brazil

[7] Inst Canc Ceara, Dept Radiotherapy, Fortaleza, Ceara, Brazil

[8] Inst Canc Ceara, Dept Med Oncol, Fortaleza, Ceara, Brazil

[9] Inst Canc Ceara, Dept Head & Neck Surg, Fortaleza, Ceara, Brazil

[10] ICESP, Dept Med Oncol, Sao Paulo, Brazil

来源：

ORAL ONCOLOGY | 2013年 / 49卷

关键词：

D O I：

10.1016/j.oraloncology.2013.03.052

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

OP044

引用

页码：S22 / S22

页数：1

共 50 条

[11] Final results of a phase III randomized trial of comparison of three paclitaxel-based regimens concurrent with radiotherapy for patients with local advanced esophageal squamous cell carcinoma.
Ai, Dashan
Ye, Jinjun
Chen, Yun
Liu, Qi
Zheng, Xiangpeng
Li, Yunhai
Wei, Shihong
Li, Jiancheng
Lin, Qin
Luo, Hui
Cao, Jianzhong
Zhou, Jialiang
Huang, Guang
Fan, Min
Wu, Kailiang
Yang, Huanjun
Zhu, Zhengfei
Zhao, Weixin
Li, Ling
Zhao, Kuaile
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[12] Long-term results of a phase II trial of induction chemotherapy with uracil-ftegafur (UFT), vinorelbine, and cisplatin (UFTVP) followed by radiotherapy concomitant with UFT and carboplatin (RT/UFTJ) in a primary site preservation setting for resectable locally advanced squamous cell carcinoma of larynx and hypopharynx
Rivera, F
Vega-Villegas, ME
López-Brea, MF
García-Castaño, A
de Juan, A
Collado, A
Galdós, P
Rubio, A
del Valle, A
Rama, J
Sanz-Ortiz, J
LARYNGOSCOPE, 2004, 114 (07): : 1163 - 1169
[13] A multicenter phase II trial of docetaxel, cisplatin and cetuximab (TPE) followed by cetuximab concurrent with radiotherapy in patients with local advanced squamous cell carcinoma of the head and neck (ECRIPS study).
Zenda, Sadamoto
Ota, Yosuke
Kiyota, Naomi
Okano, Susumu
Fujii, Masato
Kitamura, Morimasa
Takahashi, Shunji
Ueda, Tsutomu
Monden, Nobuya
Yamanaka, Takeharu
Tahara, Makoto
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[14] Phase II trial of docetaxel (T), cisplatin (P), and cetuximab (E) followed by concurrent radiation (RT), P, and E in locally advanced head and neck squamous cell carcinoma (HNSCC)
Argiris, A.
Karamouzis, M. V.
Heron, D. E.
Smith, R.
Ferris, R.
Lai, S.
Kim, S.
Branstetter, B.
Johnson, J.
Grandis, J.
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
[15] Multicenter prospective phase II trial of concurrent chemoradiotherapy with weekly low-dose carboplatin for cisplatin-ineligible patients with advanced head and neck squamous cell carcinoma
Yushi Ueki
Shusuke Ohshima
Yusuke Yokoyama
Takeshi Takahashi
Ryusuke Shodo
Keisuke Yamazaki
Kohei Ohtaki
Kohei Saijo
Ryoko Tanaka
Takafumi Togashi
Yuichiro Sato
Satoshi Takano
Jo Omata
Nao Takahashi
Ryuichi Okabe
Arata Horii
International Journal of Clinical Oncology, 2024, 29 : 20 - 26
[16] Multicenter prospective phase II trial of concurrent chemoradiotherapy with weekly low-dose carboplatin for cisplatin-ineligible patients with advanced head and neck squamous cell carcinoma
Ueki, Yushi
Ohshima, Shusuke
Yokoyama, Yusuke
Takahashi, Takeshi
Shodo, Ryusuke
Yamazaki, Keisuke
Ohtaki, Kohei
Saijo, Kohei
Tanaka, Ryoko
Togashi, Takafumi
Sato, Yuichiro
Takano, Satoshi
Omata, Jo
Takahashi, Nao
Okabe, Ryuichi
Horii, Arata
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, 29 (01) : 20 - 26
[17] Hyperfractionated radiotherapy (Hfx RT) with or without concurrent low-dose daily cisplatin (CDDP) in locally advanced unresectable squamous cell carcinoma of the head and neck (SCC H&N). A prospective randomized trial
Jeremic, B
Shibamoto, Y
Milicic, B
Nikolic, N
Dagovic, A
EUROPEAN JOURNAL OF CANCER, 1999, 35 : S163 - S163
[18] Neoadjuvant chemotherapy with albumin-bound paclitaxel plus cisplatin and capecitabine for locally advanced esophageal squamous cell carcinoma: A prospective phase II trial
Zhang, Wen
Li, Yong
Xue, Liyan
Qu, Dong
Jiang, Zhichao
Gao, Shugeng
Zhou, Aiping
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[19] Multi-omics analysis of tislelizumab plus nab-paclitaxel and cisplatin as neoadjuvant immunochemotherapy for locally advanced hypopharyngeal squamous cell carcinoma: A prospective single-arm phase II trial
Xie, Z.
Zhang, W.
Chen, X.
Wang, X.
Liu, S.
Yi, J.
An, C.
Lu, H.
Yao, J.
Zhu, H.
Xie, T.
Tang, L.
He, X.
Shi, Y.
Gui, L.
ANNALS OF ONCOLOGY, 2024, 35 : S641 - S641
[20] Paclitaxel and cisplatin combined with concurrent involved-field irradiation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma: a phase II clinical trial
Hui Li
Ying Fang
Dayong Gu
Mingyu Du
Zhi Zhang
Lei Sun
Guoren Zhou
Jinjun Ye
Radiation Oncology, 17

← 1 2 3 4 5 →